InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Alter Jeffrey D., Director. Officer active across 3 companies, notably PROGENITY, INC.. Aggregated, 6 disclosures have been published. History available since 14 June 2021. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Alter Jeffrey D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
12,500 shares0Common StockSEC:0000950170-24-069926:0
12,500 shares0Common StockSEC:0000950170-23-028595:0
65 sharesSeries X Preferred StockSEC:0000899243-23-000961:0
96,154 shares0Common StockSEC:0000899243-22-023091:0
311 shares@ US$375.93100.0% of flowCommon StockSEC:0001156039-21-000086:0
29,183 shares0Common StockSEC:0000899243-21-024202:0
6 of 6 declarations
About Alter Jeffrey D.
Jeffrey D. Alter is a Board Member and EVP, IngenioRx & Anthem Health, involved with several companies including PROGENITY, INC., Anthem, Inc., and BIORA THERAPEUTICS, INC. He plays a key role in strategic direction and operational oversight, bringing his expertise in the healthcare sector.
